OtherNeuropharmacology
Targeted antioxidative and neuroprotective properties of the dopamine agonist Pramipexole and its non- dopaminergic enantiomer SND919CL2x
Ruth Danzeisen, Birgit Schwalenstoecker, Frank Gillardon, Erich Buerger, Volker Krzykalla, Klaus Klinder, Lorenz Schild, Bastian Hengerer, Albert C. Ludolph, Cornelia Dorner-Ciossek and Lothar Kussmaul
Journal of Pharmacology and Experimental Therapeutics September 27, 2005, DOI: https://doi.org/10.1124/jpet.105.092312
Ruth Danzeisen
Birgit Schwalenstoecker
Frank Gillardon
Erich Buerger
Volker Krzykalla
Klaus Klinder
Lorenz Schild
Bastian Hengerer
Albert C. Ludolph
Cornelia Dorner-Ciossek
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherNeuropharmacology
Targeted antioxidative and neuroprotective properties of the dopamine agonist Pramipexole and its non- dopaminergic enantiomer SND919CL2x
Ruth Danzeisen, Birgit Schwalenstoecker, Frank Gillardon, Erich Buerger, Volker Krzykalla, Klaus Klinder, Lorenz Schild, Bastian Hengerer, Albert C. Ludolph, Cornelia Dorner-Ciossek and Lothar Kussmaul
Journal of Pharmacology and Experimental Therapeutics September 27, 2005, DOI: https://doi.org/10.1124/jpet.105.092312
OtherNeuropharmacology
Targeted antioxidative and neuroprotective properties of the dopamine agonist Pramipexole and its non- dopaminergic enantiomer SND919CL2x
Ruth Danzeisen, Birgit Schwalenstoecker, Frank Gillardon, Erich Buerger, Volker Krzykalla, Klaus Klinder, Lorenz Schild, Bastian Hengerer, Albert C. Ludolph, Cornelia Dorner-Ciossek and Lothar Kussmaul
Journal of Pharmacology and Experimental Therapeutics September 27, 2005, DOI: https://doi.org/10.1124/jpet.105.092312
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement